Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.
about
Pharmacological treatments for acute hepatitis B infection: a network meta-analysisPharmacological treatments for chronic hepatitis B liver disease: a network meta-analysisInterferon alpha for chronic hepatitis BLiver transplantation for viral hepatitis in 2015Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus InfectionManagement of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinomaPotential mechanisms of hepatitis B virus induced liver injuryEpidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver functionThe assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapyPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesLamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B.Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysisRegulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analysesHepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysisComparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment.Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment.Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue TherapyA critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: a novel approach by using meta-regression.Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy.Impact of therapy on the outcome of chronic hepatitis B.Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?Impact of HBV therapy on the incidence of hepatocellular carcinoma.Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.Postoperative therapy options for hepatocellular carcinoma.Improving clinical outcomes of chronic hepatitis B virus infection.Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.Does hepatitis B virus therapy reduce the risk of hepatocellular carcinoma?Chemoprevention against hepatocellular carcinoma.Monotherapy for hepatitis B infection: a review of treatment options.Pharmacotherapeutic options for hepatitis B.Prevention of hepatitis B virus-associated liver diseases by antiviral therapy.Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.Impact of etiological treatment on prognosis.Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.JSH Guidelines for the Management of Hepatitis B Virus Infection.
P2860
Q24186837-1E35463D-DBC4-4295-B910-3FE5A7A3FD97Q24186878-4C794A4B-4A2F-49E9-9676-E02B04D78617Q24235232-DE5A09E7-4C5A-4FD7-A93E-4BCB6B630384Q26773224-715E8973-0D64-4D6A-873E-7657BACB06EAQ26781962-CA7FACB3-7D99-4DDE-BDB0-E8BF2B3DCCF4Q26799056-81E9EF28-310B-4674-B69E-11B832EA93F0Q27014079-B12CBBFA-8F86-49B7-AB75-400F80808B50Q27025083-A9135BFF-696F-4B17-A5C1-3CEC602D5E8DQ28066295-69B9D2E4-E513-4A1C-BB1B-BD1BE8DB4AC8Q28075923-74442A55-C9CB-4991-8347-F42AEA442CF9Q28272678-5D5080B0-325C-4424-92CF-04FC78E7EA0BQ33985364-40123B0E-B4C1-4227-8FAD-9F6F16999088Q34391578-0CB023DF-D6A7-4F95-AF20-78262F324100Q34615975-418F890D-60CD-4DD1-B4CE-FE339F6B12B7Q34769837-14D7CA17-4E07-4787-9975-7C0EFBFFFD88Q36199751-0C81B494-3FDD-4B78-B2A9-8982F9019B44Q37117293-C34A7445-2E51-4FB0-B615-F76B9F37506CQ37343288-5778A098-4170-4BAB-AE10-891EEB58CA9EQ37429930-D6B44646-1F27-4730-AD5C-362075B46946Q37716237-0A6A22AD-4E81-4BDF-879E-616CFCDAE99AQ38007308-4171B83A-12F7-4469-BBB9-FEDD4959A3A8Q38027061-A9820226-762D-466A-9284-D08EB77179D5Q38071395-E928C9FB-9A8C-4F16-9CD1-741538BB2A1EQ38174255-4F579B1C-3425-4D6D-A504-9474C67C4E89Q38174263-A4D1B89D-4B37-4281-B37A-A358B8B1D5BFQ38174862-F6A50682-011D-4377-B055-D11139DC28C5Q38203306-5922F717-1B1B-454E-A6C9-ADCBDA0821A1Q38252962-6428E3DF-298B-43CE-B3F2-BC4C5A484663Q38259534-CC172D1F-FA8E-41EE-A7EC-29D78827CF15Q38303237-C8BF6816-85D3-4E13-9B79-1EDF9F32A508Q38550165-494CAB0B-B6C2-4EFA-B762-2BC89CCB82BAQ38594605-384D5FFB-6E01-4EEB-B1C5-04F06B7680FFQ38631076-D8EEBAB6-D3D6-4EDF-A3F1-CB229AF2E203Q38793117-5C197AE6-4DB6-4C10-A74E-C2667792C7C4Q38891837-194AFEB7-2A16-481C-B41E-8D3F33D0E4A3Q39431994-F925E87D-1772-478D-95FE-7B640767496BQ41042019-59D483E3-5307-420D-B5D1-3279B3B2830DQ41345009-FFE2E317-6F80-4D96-889A-D12E688849A5Q41921861-2F3AD55B-ED2F-4F3B-B9C5-3FD0F942D25AQ42244740-CD33D316-C8D6-49F2-9C0B-2FEF4AEDDAFE
P2860
Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interferon therapy in chronic ...... ar carcinoma: a meta-analysis.
@en
Interferon therapy in chronic ...... ar carcinoma: a meta-analysis.
@nl
type
label
Interferon therapy in chronic ...... ar carcinoma: a meta-analysis.
@en
Interferon therapy in chronic ...... ar carcinoma: a meta-analysis.
@nl
prefLabel
Interferon therapy in chronic ...... ar carcinoma: a meta-analysis.
@en
Interferon therapy in chronic ...... ar carcinoma: a meta-analysis.
@nl
P2093
P1476
Interferon therapy in chronic ...... lar carcinoma: a meta-analysis
@en
P2093
P304
P356
10.1111/J.1365-2893.2009.01070.X
P50
P577
2009-02-12T00:00:00Z